载脂蛋白B/A-1比值与2型糖尿病慢性并发症的相关研究进展  

Research Progress on the Correlation between the Apolipoprotein B/A-1 Ratio and Chronic Complications of Type 2 Diabetes

作　　者：田佳敏 李社莉[1] 

机构地区：[1]延安大学附属医院内分泌与代谢科,陕西 延安

出　　处：《临床医学进展》2024年第8期807-811,共5页Advances in Clinical Medicine

摘　　要：糖尿病的发生率逐渐升高,尤其是2型糖尿病。随着糖尿病病程的增加,各项并发症的发病率也随之升高。尤其是2型糖尿病导致的慢性并发症,对人们的健康、心理及经济等各个方面均有一定的影响。近几年的研究均表明了脂质代谢对糖尿病的发病机制及其并发症的发生及进展有一定的影响。载脂蛋白B/A-1比值作为新的代谢紊乱标志物的指标之一,可评价糖尿病患者血管相关并发症。本文就载脂蛋白B/A-1比值在2型糖尿病血管并发症中的作用的相关研究进行综述。The prevalence of type 2 diabetes is on the rise, leading to an increase in associated complications over time. In particular, the chronic complications caused by type 2 diabetes have a certain impact on people’s health, psychology and economy. Recent studies have highlighted the impact of lipid metabolism on the development and progression of diabetes-related complications. Given that the ApoB/A-1 ratio can serve as a valuable indicator for assessing metabolic disorders and evaluating chronic complications in patients with diabetes. This review provides an overview of relevant research concerning the role of ApoB/A-1 ratio in vascular complications of type 2 diabetes.

关 键 词：脂蛋白B/A-1比值 2型糖尿病 糖尿病慢性并发症 

分 类 号：R58[医药卫生—内分泌]